Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially ‘Low-Risk’ Patients
Tze‐Fan Chao(National Yang Ming Chiao Tung University), Shih‐Ann Chen(National Yang Ming Chiao Tung University), Ta‐Chuan Tuan(National Yang Ming Chiao Tung University), Gregory Y.H. Lip(Medical University of Białystok), Fa‐Po Chung(L-3 Communications (United States)), Yu‐Feng Hu(Albert Einstein College of Medicine), Li‐Wei Lo(National Yang Ming Chiao Tung University), Yenn‐Jiang Lin(National Yang Ming Chiao Tung University), Tzeng‐Ji Chen(Taipei Veterans General Hospital), Shih‐Lin Chang(National Yang Ming Chiao Tung University), Jo‐Nan Liao(L-3 Communications (United States))
Cited by 92
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k